Zevaskyn Cellular Sheet
Product Images NDC 84103-007

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zevaskyn (NDC 84103-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abeona Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Zevaskyn 01)

An instructional diagram showing a sterile field setup for handling a drug product cellular sheet. The image depicts gloved hands using forceps to manipulate the drug product, which is placed in a transport media container. A close-up inset highlights titanium ligating clips on the cellular sheet.*

FDA Label Image

Principal Display Panelprademagene Zamikeracelzevaskyngene-modified Cellular Sheetsrx Only (Zevaskyn 02)

Label for ZEVASKYN prademagene zamikeracel gene-modified cellular sheets, a topical autologous cellular sheet product. The label notes containment of up to four sheets, each 41.25 cm², with no preservatives. Manufactured and distributed by Abeona Therapeutics Inc., with storage instructions to keep at room temperature. The label includes contact information and an NDC barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.